The effect of Melissa on stress and hemodynamic parameters

Phase 3

Recruiting

Conditions: Condition 1: Acute coronary syndrom. Condition 2: Stress. Condition 3: Aromatherapy. Condition 4: Mean atrial pressure and Heart rate.
Non-ST elevation (NSTEMI) myocardial infarction
I21.4
F43.0
Acute stress reaction

Registration Number: IRCT20150919024080N14

Lead Sponsor: Khoram-Abad University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 72

Inclusion Criteria

Definitive diagnosis of acute coronary syndrome by a specialist based on evidence based electrocardiogram and clinical signs and troponin index
No respiratory disease such as asthma and COPD and allergies or allergies to plants
Entering the emergency department without cardiac arrest
Vigilance and Awareness of place, time and person
No history of head trauma and seizure
No history of confirmed mental illness
No opium and alcohol addiction
No history of PTSD in during the last six months
No history of using other complementary therapies for at least one month before intervention
No disruption of sense of smell
Mean arterial blood pressure more than 90 and heart rate more than 60
Patients with chest pain severity of 3 and more based on visual analogue scale (VAS)
Age over 35 and under 65 years

Exclusion Criteria

Patients Candidate for primary PCI
Patient's unwillingness to continue participation
Unstable hemodynamic (20% change compared to time of start intervention)
Incidence of arrhythmias and allergic and respiratory problems during intervention
Transfer patients from the emergency department to the intensive care unit in less than 3 hours
Patient connection to mechanical ventilation

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Stress score in DASS-21 questionnaire. Timepoint: Before intervention, 5 and 15 minutes after the end of aromatherapy on two occasions of aromatherapy. Method of measurement: DASS-21 Stress Questionnaire.;Mean Atrial Pressure. Timepoint: Before intervention, 5 and 15 minutes after the end of aromatherapy on two occasions of aromatherapy. Method of measurement: Cardiac Monitoring machine.;Heart rate. Timepoint: Before intervention, 5 and 15 minutes after the end of aromatherapy on two occasions of aromatherapy. Method of measurement: Cardiac Monitoring machine.;Threat perception score. Timepoint: Before and the end of intervention. Method of measurement: Threat Perception Questionnaire.

Secondary Outcome Measures

Name	Time	Method
??? ?? ??????pain. Timepoint: Before the intervention, 5 and 15 minutes after the intervention in two aromatherapy treatments. Method of measurement: Visual Analogue Scale.